211 related articles for article (PubMed ID: 26369630)
1. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone.
Koch R; Aung T; Vogel D; Chapuy B; Wenzel D; Becker S; Sinzig U; Venkataramani V; von Mach T; Jacob R; Truemper L; Wulf GG
Clin Cancer Res; 2016 Jan; 22(2):395-404. PubMed ID: 26369630
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
Ye CG; Wu WK; Yeung JH; Li HT; Li ZJ; Wong CC; Ren SX; Zhang L; Fung KP; Cho CH
Cancer Lett; 2011 May; 304(2):90-6. PubMed ID: 21377266
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
Front Immunol; 2021; 12():692654. PubMed ID: 34149737
[TBL] [Abstract][Full Text] [Related]
5. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.
Aung T; Chapuy B; Vogel D; Wenzel D; Oppermann M; Lahmann M; Weinhage T; Menck K; Hupfeld T; Koch R; Trümper L; Wulf GG
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15336-41. PubMed ID: 21873242
[TBL] [Abstract][Full Text] [Related]
6. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract][Full Text] [Related]
7. Pixantrone: novel mode of action and clinical readouts.
Minotti G; Han H; Cattan V; Egorov A; Bertoni F
Expert Rev Hematol; 2018 Jul; 11(7):587-596. PubMed ID: 29912583
[TBL] [Abstract][Full Text] [Related]
8. Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells.
Harmati M; Tarnai Z; Decsi G; Kormondi S; Szegletes Z; Janovak L; Dekany I; Saydam O; Gyukity-Sebestyen E; Dobra G; Nagy I; Nagy K; Buzas K
J Oral Pathol Med; 2017 Apr; 46(4):259-266. PubMed ID: 27598726
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Khan FM; Saleh E; Alawadhi H; Harati R; Zimmermann WH; El-Awady R
Cancer Biol Ther; 2018 Jan; 19(1):25-33. PubMed ID: 29244610
[TBL] [Abstract][Full Text] [Related]
10. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
[TBL] [Abstract][Full Text] [Related]
11. Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Willenbacher E; Jöhrer K; Willenbacher W; Flögel B; Greil R; Kircher B
Ann Hematol; 2019 Nov; 98(11):2569-2578. PubMed ID: 31628518
[TBL] [Abstract][Full Text] [Related]
12. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.
Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G
J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654
[TBL] [Abstract][Full Text] [Related]
13. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.
Kong JN; He Q; Wang G; Dasgupta S; Dinkins MB; Zhu G; Kim A; Spassieva S; Bieberich E
Int J Cancer; 2015 Oct; 137(7):1610-20. PubMed ID: 25833198
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma.
Jamal-Hanjani M; Pettengell R
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1441-8. PubMed ID: 21905966
[TBL] [Abstract][Full Text] [Related]
15. [INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)].
Trashkov AP; Vasil'ev AG; Kovalenko AL; Petrov AY; Valeev VV
Eksp Klin Farmakol; 2016; 79(2):34-9. PubMed ID: 27416681
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.
Ageberg M; Rydström K; Lindén O; Linderoth J; Jerkeman M; Drott K
Exp Cell Res; 2011 May; 317(8):1179-91. PubMed ID: 21324313
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry.
Zinzani PL; Bregni M; Spione M; Mitterer M; Musuraca G; Bugli A; Piazza F; Pinto A
Acta Haematol; 2021; 144(3):259-263. PubMed ID: 33040061
[TBL] [Abstract][Full Text] [Related]
18. The role of pixantrone in the treatment of non-Hodgkin's lymphoma.
Borchmann P; Schnell R
Expert Opin Investig Drugs; 2005 Aug; 14(8):1055-61. PubMed ID: 16050797
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy.
Kim IS; Kim HG; Kim DC; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Lee GW
Cancer Sci; 2008 Dec; 99(12):2496-501. PubMed ID: 19032367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
